Primary Category:
Treatment Protocols
Disease Category:
Lung - Small Cell Extensive Stage
Status:
New, Open
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)
NCT#04334941
